Vyro in the Media: R7 highlights the innovative role of the Zika Virus.

Last Saturday (23), Vyro was featured on Portal R7 (@portalr7), with the participation of Dr. Carolini Kaid, our CEO/CSO and scientist who has been studying the Zika virus since 2018, which caused an epidemic in Brazil between 2015 and 2016. Today known as Oryvik, this new genetically modified version was developed to specifically target tumor cells, offering promising prospects in cancer treatment, especially in the central nervous system. Our team of scientists is exploring new frontiers in the field of viral therapy, turning a once feared pathogen into a potential ally in the fight against cancer. It is exciting to see our work recognized in the media. We look forward to sharing further research advancements and making a positive impact on society.